PCF to Fund More than 30 new Projects to Accelerate Prostate Cancer Research
News Jan 08, 2010
The Prostate Cancer Foundation (PCF) has announced that it will fund at least 10 new Creativity and 20 new multi-year Young Investigator Awards in the first half of 2010.
These grants will support research ideas and encourage new ideas from some of the brightest young minds in the field of cancer research. This new round of funding will support many projects that would otherwise be left unfunded due to cutbacks in federal funding and the global recession.
"We are delighted to announce that we will be funding more than 30 new game-changing research projects in 2010 in addition to the 48 research programs that we are already supporting," commented Jonathan W. Simons, M.D., President, CEO and David H. Koch Chair of the Prostate Cancer Foundation. "The commitment of our donors enables us to continue advancing cancer research at a time when other funding sources are shrinking. In 2009, PCF donors contributed more than U.S. $36.5 million-just shy of our 2008 total of $37.2 million-to support PCF's research enterprise. Gifts to the PCF ranged from $5.00 to $5 million. We are grateful to our supporters, both large and small, for making ongoing research progress against prostate cancer possible."
PCF funded 10 Creativity Awards in 2009 and 20 Young Investigators in 2008. The foundation will release its list of 2010 Young Investigators in March. The deadline for the Creativity Awards Request for Applications is January 31.
Immune Cells That Keep Gut Fungi Under Control IdentifiedNews
Immune cells that process food and bacterial antigens in the intestines control the intestinal population of fungi, according to a new study from Weill Cornell Medicine scientists.READ MORE
New Biomarkers Predict Outcome of Cancer ImmunotherapyNews
Researchers at the University of Zurich have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Patients for whom therapy does not work can thus be treated using different methods at an earlier stage.READ MORE
New Preservation Method Maintains Viable CTCs for up to 72 HoursNews
A new blood stabilization method significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells.READ MORE
Comments | 0 ADD COMMENT
Precision Medicine & Biomarkers Leaders Summit: USA
May 07 - May 08, 2018